As Isomorphic Labs aims its artificial intelligence tools at drug development, it’s setting up a new outpost in the biotech ...

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...

Frontier IP announced on Friday that it has entered into a strategic partnership with property developer Abstract Mid-Tech to ...

Frontier IP, a specialist in commercialising intellectual property is working in partnership to create a novel innovation hub ...

AstraZeneca has signed a research agreement worth more than US$5 billion with Chinese drugmaker CSPC Pharmaceutical Group, ...

“Straight out of the blocks,” he says, “Cambridge Wide Open Week has been a whirlwind of inspiring pitches, thought-provoking ...

But private sector companies like AstraZeneca are pushing forward with major investments in life sciences research and manufacturing. The Cambridge, U.K.-based pharmaceutical giant on Monday ...

While the Cambridge-based company is still waiting ... as trade tensions shift the global focus to the US – AstraZeneca’s biggest market. It came a day after Beijing touted itself as a meditech hub ...

Oxford and Cambridge, which are renowned for their contributions to science, technology, and innovation. The area is also home to established tech companies like Microsoft, Amazon, and AstraZeneca.

with the manufacturing and logistics hub of Milton Keynes in between. “The Oxford-Cambridge Arc is already an engine of prosperity, but we can go even further. We are determined to unleash ...

Citing a rosy view of the U.S. economy’s potential for growth over the next several years, British Big Pharma AstraZeneca is ... to set up an R&D center in Cambridge, Massachusetts’ Kendall ...